Amgen breaks ground on next-generation biomanufacturing plant in Rhode Island

Amgen (NASDAQ:AMGN) today announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the first-of-its-kind in the U.S. and will use Amgen's proven next-generation biomanufacturing capabilities to manufacture products for the U.S. and global markets.

Source: World Pharma News - August 2, 2018 Category: Pharmaceuticals Tags: Featured Amgen Business and Industry Source Type: news